VOLITIONRX LTD — Capital/Financing Update 2015

Feb 6, 2015

8-K 1 f8k020515_8k.htm FORM 8-K CURRENT REPORT html PUBLIC "-//IETF//DTD HTML//EN" FORM 8-K Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 6, 2015

VolitionRX Limited
(Exact name of registrant as specified in its charter)

Delaware	000-30402	91-1949078
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1 Scotts Road
#24-05 Shaw Centre
Singapore 228208
(Address of principal executive offices and Zip Code)
+1 (646) 650-1351
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

. Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

. Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

. Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

. Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events.

On February 6, 2015, VolitionRX Limited (the “ Company ”) issued a press release announcing the pricing of a public offering of 2,475,000 shares of common stock. A copy of the press release is filed herewith as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.	Description
99.1	Press release dated February 6, 2015.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: February 6, 2015

VolitionRX Limited

By: /s/ Cameron Reynolds

Cameron Reynolds

Chief Executive Officer

3

INDEX TO EXHIBITS FILED WITH THIS REPORT

Exhibit No.	Description
99.1	Press release dated February 6, 2015.

4

EDGAR Validation Code: 41A29F1F